Results 251 to 260 of about 5,665,898 (300)

Q&A: Louis Staudt on Molecular Classification of Cancer. [PDF]

Blood Cancer Discov
europepmc   +1 more source

Molecular Classification of Resected Primary Duodenal Adenocarcinoma. [PDF]

Genes Chromosomes Cancer
de Bakker J, Biesma H, Soeratram T, Egthuijsen J, de Back T, Besselink M, Vermeulen L, Ylstra B, van Grieken N, Kazemier G.   +9 more
europepmc   +1 more source

A clinically relevant morpho-molecular classification of lung neuroendocrine tumours

Sexton-Oates A, Mathian É, Candeli N, Lim Y, Voegele C, Di Genova A, Mangé L, Li Z, van Weert T, Hillen LM, Blázquez-Encinas R, Gonzalez-Perez A, Morrison ML, Lauricella E, Mangiante L, Bonheme L, Moonen L, Absenger G, Altmuller J, Degletagne C, Brustugun OT, Cahais V, Centonze G, Chabrier A, Cuenin C, Damiola F, de Montpréville VT, Deleuze J, Dingemans AC, Fadel É, Gadot N, Ghantous A, Graziano P, Hofman P, Hofman V, Ibáñez-Costa A, Lacomme S, Lopez-Bigas N, Lund-Iversen M, Milione M, Muscarella LA, Pedraza-Arevalo S, Perrin C, Planchard G, Popper H, Roz L, Sparaneo A, Buikhuisen W, van den Berg J, Tesselaar M, Kim J, Speel EJM, Tabone-Eglinger S, Walter T, Wright GM, Castaño JP, Chalabreysse L, Chen L, Caux C, Volante M, Girard N, Vignaud J, Conde E, Mansuet-Lupo A, Brcic L, Pelosi G, Papotti MG, Lantuejoul S, Derks J, Dayton T, Alcala N, Foll M, Fernandez-Cuesta L.   +72 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Molecular classification of cholangiocarcinoma

Current Opinion in Gastroenterology, 2020
Purpose of review Cholangiocarcinoma (CCA) are heterogeneous tumors that arise from the malignant transformation of cholangiocytes along the biliary tree. CCA heterogeneity occurs at multiple levels and results in resistance to therapy and poor prognosis.
Louis, Corentin, Papoutsoglou, Panagiotis, Coulouarn, Cedric   +2 more
openaire   +3 more sources

Molecular Classification of Breast Cancer

PET Clinics, 2023
Breast carcinomas classified based on traditional morphologic assessment provide useful prognostic information. Although morphology is still the gold standard of classification, recent advances in molecular technologies have enabled the classification of these tumors into four distinct subtypes based on its intrinsic molecular profile that provide both
Madhuchhanda, Roy, Amy M, Fowler, Gary A, Ulaner, Aparna, Mahajan   +3 more
openaire   +2 more sources

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine

International Journal of Molecular Sciences, 2016
Neurodegenerative diseases (NDDs) are characterized by selective dysfunction and loss of neurons associated with pathologically altered proteins that deposit in the human brain but also in peripheral organs.
Gabor G Kovacs
exaly   +2 more sources

Molecular classification of the dementias

The Lancet, 2000
Most patients with frontotemporal dementia do not have taupathology as shown by immunohistochemistry. The use of the term tauopathy to classify frontotemporal dementia is inappropriate.
Mann, D M, McDonagh, A M, Snowden, J, Neary, D, Pickering-Brown, S M   +4 more
openaire   +3 more sources

Discovering Interesting Molecular Substructures for Molecular Classification

IEEE Transactions on NanoBioscience, 2010
Given a set of molecular structure data preclassified into a number of classes, the molecular classification problem is concerned with the discovering of interesting structural patterns in the data so that "unseen" molecules not originally in the dataset can be accurately classified. To tackle the problem, interesting molecular substructures have to be
Winnie W M, Lam, Keith C C, Chan
openaire   +2 more sources

Molecular classification of gliomas

2016
The identification of distinct genetic and epigenetic profiles in different types of gliomas has revealed novel diagnostic, prognostic, and predictive molecular biomarkers for refinement of glioma classification and improved prediction of therapy response and outcome. Therefore, the new (2016) World Health Organization (WHO) classification of tumors of
Kenta, Masui, Paul S, Mischel, Guido, Reifenberger   +2 more
openaire   +2 more sources

Molecular Characterization and Classification of Neuroblastoma

Future Oncology, 2009
For many decades, neuroblastoma has remained a challenging disease for both clinicians and researchers. Now, techniques that efficiently specify both comprehensive genetic and gene-expression alterations of neuroblastoma tumors have provided molecular markers that indicate tumor behavior and patient outcome with very high accuracy. Once the anticipated
André, Oberthuer, Jessica, Theissen, Frank, Westermann, Barbara, Hero, Matthias, Fischer   +4 more
openaire   +2 more sources